Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases

Breast

Volumn 21, Issue 4, 2012, Pages 518-523

  Boler, D E ^a   Uras, C ^a   Ince, U ^a   Cabioglu, N ^a  

^a ACIBADEM UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Extracapsular invasion; HER2; Isolated tumor cells; Luminal A; Luminal B; Micrometastasis; Non sentinel lymph node metastases; Sentinel lymph node metastasis; Triple negative

Indexed keywords

CYTOKERATIN;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; EXTRACAPSULAR INVASION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; VALIDATION PROCESS;

EID: 84863872259     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.02.012     Document Type: Article

References (52)

1. Harlow S.P., Krag D.N., Julian T.B., et al. Prerandomization surgical training for the national surgical adjuvant breast and bowel project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005, 241:48-54.
2. Straver M.E., Meijnen P., van Tienhoven G., et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 2010, 17:1854-1861.
3. Straver M.E., Meijnen P., van Tienhoven G., et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 2010, 28:731-737.
4. Veronesi U., Viale G., Paganelli G., et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010, 251:595-600.
5. Erb K.M., Julian T.B. Completion of axillary dissection for a positive sentinel node: necessary or not?. Curr Oncol Rep 2009, 11:15-20. Review.
6. Giuliano A.E., Hunt K.K., Ballman K.V., et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 305:569-575.
7. van Iterson V., Leidenius M., Krogerus L., von Smitten K. Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 2003, 82:39-45.
8. Van Zee K.J., Manasseh D.M.E., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003, 10:1140-1151.
9. Degnim A.C., Reynolds C., Pantvaidya G., et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005, 190:543-550.
10. Chagpar A.B., Scoggins C.R., Martin R.C., et al. University of Louisville breast sentinel lymph node study. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg 2006, 192:882-887.
11. Viale G., Maiorano E., Pruneri G., et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005 Feb, 241(2):319-325.
12. Nos C., Harding-MacKean C., Fréneaux P., Trie A., Falcou M.C., Sastre-Garau X., et al. Prediction of tumor involvement in remaining axillary lymph nodes when the sentinel node in a women with breast cancer contains metastases. Br J Surg 2003, 90:1354-1360.
13. Houvenaeghel G., Nos C., Mignotte H., et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 2006, 24:1814-1822.
14. van Deurzen C.H., van Hillegersberg R., Hobbelink M.G., Seldenrijk C.A., Koelemij R., van Diest P.J. Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases. Cell Oncol 2007, 29:497-505.
15. Cserni G., Gregory D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 2004, 91:1245-1252.
16. Andersson Y., Frisell J., Sylvan M., de Boniface J., Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 2010, 28:2868-2873.
17. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., Wolmark N. Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Eng J Med 2002, 347:567-575.
18. Krag D.N., Anderson S.J., Julain T.B., et al. Sentinel-lymph-node resection compared with conventinel axillary-lymph-node dissection in clinially node-negative patients with breast cancer: overall survival findings from the NSABP-32 randomised phase 3 trial. Lancet Oncol 2010, 11:927-933.
19. Wernicke A.G., Goodman R.L., Turner B.C., et al. A 10-year follow-up of treatment outcomes in patients with early breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat 2011, 125:893-902.
20. Veronesi U., Orecchia R., Zurrida S., et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 2005, 16:383-388.
21. Rastogi P., Anderson S.J., Bear H.D., et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008, 26:778-785.
22. Martelli G., Boracchi P., De Palo M., et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg 2005, 242:1-6.
23. Giuliano A.E., McCall L., Beitsch P., et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial. Ann Surg 2010, 252:426-432.
24. Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al.International Breast Cancer Study Group Trial 23-01 Investigators. S3-1. Update of international breast cancer study group trial 23-01 to compare axillary dissection versus no axillary dissection in patients with clinically node negative breast cancer and micrometastases in the sentinel node. CTRC-AACR San Antanio breast cancer symposium, San Antanio, Texas, USA; December 6-10, 2011.
25. Hwang R.F., Krishnamurthy S., Hunt K.K., et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003, 10:248-253.
26. Wong S.L., Edwards M.J., Chao C., et al. Predicting the status of the nonsentinel axillary nodes. Arch Surg 2001, 136:563-568.
27. Reynolds C., Mick R., Donohue J.H., et al. Sentinel lymph node biopsy with metastasis:can axillary dissection be avoided in some patients with breast cancer?. J Clin Oncol 1999, 17:1720-1726.
28. Joseph K.A., El-Tamer M., Komenaka I., Troxel A., Ditkoff B.A., Schnabel F. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 2004, 139:648-651.
29. Turner R.R., Ku Chu, Qi K., Hansen N.M., Glass E.C., Giuliano A.E. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000, 89:574-581.
30. Kamath V.J., Giuliano R., Dauway E.L., et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001, 136:688-692.
31. Ozmen V., Karanlik H., Cabioglu N., et al. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 2006, 95:1-6.
32. Abdessalam S.F., Zervos E.E., Prasad M., et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001, 182:316-320.
33. Rahusen F.D., Torrenga H., van Diest P.J., Pijpers R., van der Wall E., Licht J., et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001, 136:1059-1063.
34. Degnim A.C., Griffith K.A., Sabel M.S., et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients: a metaanalysis. Cancer 2003, 98:2307-2315.
35. Rutledge H., Davis J., Chiu R., Cibull M., Brill Y., McGrath P., et al. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 2005, 18:762-768.
36. Fournier K., Schiller A., Perry R.R., Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 2004, 239:859-865.
37. Viale G., Maiorano E., Mazzarol G., et al. Histologic detection and clinical implications of micrometastasis in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001, 92:1378-1384.
38. Menes T.S., Tartter P.I., Mizrachi H., Constantino J., Estabrook A., Smith S.R. Breast cancer patients with pN0(i+) and pN1(mi) sentinel nodes have high rate of nonsentinel node metastases. J Am Coll Surg 2005, 200:323-327.
39. Chu K.U., Turner R.R., Hansen N.M., Brennan M.B., Bilchik A., Giuliano A.E. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?. Ann Surg 1999, 229:536-541.
40. Weiser M.R., Montgomery L.L., Tan L.K., Susnik B., Leung D.Y., Borgen P.I., et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001, 8:145-149.
41. Stitzenberg K.B., Meyer A.A., Stern S.L., et al. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg 2003, 237:607-612.
42. den Bakker M.A., van Weeszenberg, de Kanter A.Y., Beverdam F.H., Pritchard C., van der Kwast T.H., et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 2002, 55:932-935.
43. Lambert L.A., Ayers G.D., Hwang R.F., et al. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after a positive sentinel lymph node biopsy. Ann Surg Oncol 2006, 13:310-320.
44. Alran S., DeRycke Y., Fourchotte V., et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 2007, 14:2195-2201.
45. Kohrt H.E., Olshen R.A., Berma H.R., et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008, 8:66.
46. Chagpar A.B., Scoggins C.R., Martin R.C., et al. University of Louisville breast sentinel lymph node study. Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 2007, 14:670-677.
47. Chagpar A.B., McMasters K.M. Comparing prediction models: the distinction between clinical and statistical significance. Ann Surg Oncol 2011, 18(Suppl. 3):S265.
48. AJCC cancer staging handbook 2009, Springer. 7th ed. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
49. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874.
50. Wada N., Imoto S., Yamauchi C., Hasebe T., Ochiai A. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol 2006, 32:29-33.
51. Rivers A.K., Griffith K.A., Hunt K.K., et al. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 2006, 13:36-44.
52. Saidi R.F., Dudrick P.S., Remine S.G., Mittal V.K. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 2004, 70:101-105.